Adipose triglyceride lipase and hormone-sensitive lipase are involved in fat loss in JunB-deficient mice

Endocrinology

Volumn 152, Issue 7, 2011, Pages 2678-2689

  Pinent, Montserrat ^a,g   Prokesch, Andreas ^a   Hackl, Hubert ^b   Voshol, Peter J ^c   Klatzer, Ariane ^a   Walenta, Evelyn ^a   Panzenboeck, Ute ^a   Kenner, Lukas ^d,e   Trajanoski, Zlatko ^b   Hoefler, Gerald ^f   Bogner Strauss, Juliane G ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SMZO Donauspital   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; HORMONE SENSITIVE LIPASE; PERILIPIN; TRANSCRIPTION FACTOR JUNB; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; FIBROBLAST; IN VITRO STUDY; KNOCKOUT MOUSE; LIPOLYSIS; MALE; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN METABOLISM; SKELETAL MUSCLE; SURVIVAL RATE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOSITY; ANIMALS; CROSSES, GENETIC; DIETARY FATS; GENE EXPRESSION REGULATION; GROWTH DISORDERS; INSULIN RESISTANCE; LIPASE; LIPOLYSIS; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-JUN; STEROL ESTERASE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959488186     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1477     Document Type: Article

References (64)

1. Shaulian E, Karin M 2002 AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136 (Pubitemid 34521026)
2. Shaulian E 2010 AP-1-the Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 22:894-899
3. Passegué E, Wagner EF 2000 JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 19:2969-2979 (Pubitemid 30386768)
4. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M 2000 Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19:2056-2068 (Pubitemid 30237581)
5. Andrecht S, Kolbus A, Hartenstein B, Angel P, Schorpp-Kistner M 2002 Cell cycle promoting activity of JunB through cyclin A activation. J Biol Chem 277:35961-35968
6. Guinea-Viniegra J, Zenz R, Scheuch H, Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M, Wagner EF 2009 TNFα shedding and epidermal inflammation are controlled by Jun proteins. Genes Dev 23:2663-2674
7. Yogev O, Goldberg R, Anzi S, Yogev O, Shaulian E 2010 Jun proteins are starvation-regulated inhibitors of autophagy. Cancer Res 70:2318-2327
8. Hansen L, Gaster M, Oakeley EJ, Brusgaard K, Damsgaard Nielsen EM, Beck-Nielsen H, Pedersen O, Hemmings BA 2004 Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes. Biochem Biophys Res Commun 323:685-695 (Pubitemid 39221150)
9. Sartipy P, Loskutoff DJ 2003 Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-α. J Biol Chem 278:52298-52306 (Pubitemid 38035818)
10. Coletta DK, Balas B, Chavez AO, Baig M, Abdul-Ghani M, Kashyap SR, Folli F, Tripathy D, Mandarino LJ, Cornell JE, Defronzo RA, Jenkinson CP 2008 Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 294:E910-E917
11. Mizuno TM, Funabashi T, Kleopoulos SP, Mobbs CV 2004 Specific preservation of biosynthetic responses to insulin in adipose tissue may contribute to hyperleptinemia in insulin-resistant obese mice. J Nutr 134:1045-1050 (Pubitemid 38619937)
12. Hoene M, Franken H, Fritsche L, Lehmann R, Pohl AK, Häring HU, Zell A, Schleicher ED, Weigert C 2010 Activation of the mitogen-activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise. Diabetologia 53:1131-1141
13. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6:985-990
14. Mariani O, Brennetot C, Coindre JM, Gruel N, Ganem C, Delattre O, Stern MH, Aurias A 2007 JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11:361-374 (Pubitemid 46518313)
15. Passegué E, Jochum W, Schorpp-Kistner M, Möhle-Steinlein U, Wagner EF 2001 Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104:21-32 (Pubitemid 32144969)
16. Passegué E, Wagner EF, Weissman IL 2004 JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119:431-443 (Pubitemid 39423844)
17. Kenner L, Hoebertz A, Beil T, Keon N, Karreth F, Eferl R, Scheuch H, Szremska A, Amling M, Schorpp-Kistner M, Angel P, Wagner EF 2004 Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164:613-623 (Pubitemid 38233322)
18. Hess J, Hartenstein B, Teurich S, Schmidt D, Schorpp-Kistner M, Angel P 2003 Defective endochondral ossification in mice with strongly compromised expression of JunB. J Cell Sci 116:4587-4596 (Pubitemid 37461613)
19. Bogner-Strauss JG, Prokesch A, Sanchez-Cabo F, Rieder D, Hackl H, Duszka K, Krogsdam A, Di Camillo B, Walenta E, Klatzer A, Lass A, Pinent M, Wong WC, Eisenhaber F, Trajanoski Z 2010 Reconstruction of gene association network reveals a transmembrane protein required for adipogenesis and targeted by PPARγ. Cell Mol Life Sci 67:4049-4064
20. Todaro GJ, Green H 1963 Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17:299-313
21. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM 2001 Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 276:34167-34174
22. Pabinger S, Thallinger GG, Snajder R, Eichhorn H, Rader R, Trajanoski Z 2009 QPCR: application for real-time PCR data management and analysis. BMC Bioinformatics 10:268
23. Agustsson T, Rydén M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, Isaksson B, Permert J, Arner P 2007 Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67:5531-5537 (Pubitemid 46997295)
24. Rydén M, Agustsson T, Laurencikiene J, Britton T, Sjölin E, Isaksson B, Permert J, Arner P 2008 Lipolysis-not inflammation, cell death, or lipogenesis-is involved in adipose tissue loss in cancer cachexia. Cancer 113:1695-1704
25. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF 2005 Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-375 (Pubitemid 41613493)
26. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS 2002 Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935
27. Rydén M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P 2004 Targets for TNF-α-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318:168-175 (Pubitemid 38526261)
28. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS 1998 Overexpression of perilipin A and B blocks the ability of tumor necrosis factor α to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273:24665-24669 (Pubitemid 28454965)
29. Bézaire V, Mairal A, Anesia R, Lefort C, Langin D 2009 Chronic TNFα and cAMP pre-treatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis. FEBS Lett 583:3045-3049
30. Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L, Lonnqvist F, Arner P 2002 Mapping of early signaling events in tumor necrosis factor-α-mediated lipolysis in human fat cells. J Biol Chem 277:1085-1091 (Pubitemid 34968854)
31. Large V, Arner P, Reynisdottir S, Grober J, Van Harmelen V, Holm C, Langin D 1998 Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J Lipid Res 39:1688-1695 (Pubitemid 28377934)
32. Holm C, Osterlund T, Laurell H, Contreras JA 2000 Molecular mechanisms regulating hormone-sensitive lipase and lipolysis.Annu Rev Nutr 20:365-393
33. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS 2006 Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55:148-157 (Pubitemid 43343310)
34. Lafontan M, Langin D 2009 Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48:275-297
35. Rydén M, Arner P 2007 Fat loss in cachexia: is there a role for adipocyte lipolysis? Clin Nutr 26:1-6
36. Bosaeus I, Daneryd P, Svanberg E, Lundholm K 2001 Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93:380-383 (Pubitemid 32592057)
37. Shaw JH, Wolfe RR 1987 Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding. Ann Surg 205:368-376
38. Gonçalves N, Roncon-Albuquerque Jr R, Oliveira M, Quina-Rodrigues C, Lourenço AP, Leite-Moreira AF 2010 A high-calorie diet attenuates cachexia and adipose tissue inflammation in monocrotaline-induced pulmonary hypertensive rats. Rev Port Cardiol 29:391-400
39. Kim HJ, Vaziri ND, Norris K, An WS, Quiroz Y, Rodriguez-Iturbe B 2010 High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol 14:536-547
40. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJ 1999 Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20:683-693 (Pubitemid 29204354)
41. Wilson DO, Rogers RM, Wright EC, Anthonisen NR 1989 Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 139:1435-1438
42. Jakobsson P, Jorfeldt L, von Schenck H 1995 Fat metabolism and its response to infusion of insulin and glucose in patients with advanced chronic obstructive pulmonary disease. Clin Physiol 15:319-329
43. Heijligenberg R, Romijn JA, Klein S, Endert E, Sauerwein HP 1997 Lipolytic sensitivity to catecholamines in patients with human immunodeficiency virus infection. Am J Clin Nutr 66:633-638 (Pubitemid 27366789)
44. Rahn Landström T, Mei J, Karlsson M, Manganiello V, Degerman E 2000 Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor α and cAMP. Biochem J 346(Pt 2):337-343 (Pubitemid 30148118)
45. Gasic S, Tian B, Green A 1999 Tumor necrosis factor α stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 274:6770-6775 (Pubitemid 29111100)
46. Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS 2002 Exclusive action of transmembrane TNFα in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 143:1502-1511 (Pubitemid 34274381)
47. Laurencikiene J, van Harmelen V, Arvidsson Nordström E, Dicker A, Blomqvist L, Näslund E, Langin D, Arner P, Rydén M 2007 NF-κB is important for TNF-α-induced lipolysis in human adipocytes. J Lipid Res 48:1069-1077 (Pubitemid 46708674)
48. Green A, Dobias SB, Walters DJ, Brasier AR 1994 Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 134:2581-2588 (Pubitemid 24170874)
49. Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM 2006 The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARγ. Am J Physiol Endocrinol Metab 291:E115-E127 (Pubitemid 44035316)
50. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M 2005 Isoproterenol, TNFα, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 240:43-49
51. Li L, Yang G, Shi S, Yang M, Liu H, Boden G 2009 The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-α (TNF-α) in vivo. Cytokine 45:12-19
52. Sumida M, Sekiya K, Okuda H, Tanaka Y, Shiosaka T 1990 Inhibitory effect of tumor necrosis factor on gene expression of hormone sensitive lipase in 3T3-L1 adipocytes. J Biochem 107:1-2 (Pubitemid 20027258)
53. Guilherme A, Tesz GJ, Guntur KV, Czech MP 2009 Tumor necrosis factor-α induces caspase-mediated cleavage of peroxisome proliferator-activated receptor γ in adipocytes. J Biol Chem 284:17082-17091
54. Deng T, Shan S, Li PP, Shen ZF, Lu XP, Cheng J, Ning ZQ 2006 Peroxisome proliferator-activated receptor-γ transcriptionally upregulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology 147:875-884 (Pubitemid 43113005)
55. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS 2007 PPARγ regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 293:E1736-E1745 (Pubitemid 350255127)
56. Dalen KT, Schoonjans K, Ulven SM, Weedon-Fekjaer MS, Bentzen TG, Koutnikova H, Auwerx J, Nebb HI 2004 Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-γ. Diabetes 53:1243-1252 (Pubitemid 38569010)
57. Zhao S, Dong S 2008 Effect of tumor necrosis factor α on cholesterol efflux in adipocytes. Clin Chim Acta 389:67-71
58. Cawthorn WP, Sethi JK 2008 TNF-α and adipocyte biology. FEBS Lett 582:117-131
59. Duan SZ, Ivashchenko CY, Whitesall SE, D'Alecy LG, Duquaine DC, Brosius 3rd FC, Gonzalez FJ, Vinson C, Pierre MA, Milstone DS, Mortensen RM 2007 Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality. J Clin Invest 117:812-822 (Pubitemid 46348540)
60. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C 1998 Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181 (Pubitemid 28496262)
61. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182-3194 (Pubitemid 28496263)
62. Reue K, Phan J 2006 Metabolic consequences of lipodystrophy in mouse models. Curr Opin Clin Nutr Metab Care 9:436-441 (Pubitemid 44097814)
63. Frayn KN, Tan GD, Karpe F 2007 Adipose tissue: a key target for diabetes pathophysiology and treatment? Horm Metab Res 39:739-742
64. Karpe F, Tan GD 2005 Adipose tissue function in the insulin-resistance syndrome. Biochem Soc Trans 33:1045-1048 (Pubitemid 41659110)